Correlation Between Aptorum Group and Eledon Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Aptorum Group and Eledon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptorum Group and Eledon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aptorum Group Ltd and Eledon Pharmaceuticals, you can compare the effects of market volatilities on Aptorum Group and Eledon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptorum Group with a short position of Eledon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptorum Group and Eledon Pharmaceuticals.

Diversification Opportunities for Aptorum Group and Eledon Pharmaceuticals

-0.59

Correlation Coefficient

Aptorum Group  Eledon Pharmaceuticals

Excellent diversification

The 3 months correlation between Aptorum and Eledon is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Aptorum Group Ltd and Eledon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eledon Pharmaceuticals and Aptorum Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptorum Group Ltd are associated (or correlated) with Eledon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eledon Pharmaceuticals has no effect on the direction of Aptorum Group i.e., Aptorum Group and Eledon Pharmaceuticals go up and down completely randomly.

Pair Corralation between Aptorum Group and Eledon Pharmaceuticals

Considering the 90-day investment horizon Aptorum Group Ltd is expected to generate 6.92 times more return on investment than Eledon Pharmaceuticals. However, Aptorum Group is 6.92 times more volatile than Eledon Pharmaceuticals. It trades about 0.3 of its potential returns per unit of risk. Eledon Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest  73.00  in Aptorum Group Ltd on October 4, 2024 and sell it today you would earn a total of  147.00  from holding Aptorum Group Ltd or generate 201.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Aptorum Group Ltd  vs.  Eledon Pharmaceuticals

Aptorum Group

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aptorum Group Ltd are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Aptorum Group displayed solid returns over the last few months and may actually be approaching a breakup point.

Eledon Pharmaceuticals

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aptorum Group and Eledon Pharmaceuticals

The main advantage of trading using opposite Aptorum Group and Eledon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptorum Group position performs unexpectedly, Eledon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will offset losses from the drop in Eledon Pharmaceuticals' long position.

The idea behind Aptorum Group Ltd and Eledon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.